Ufuk 2020 Sağlık, Demografik Değişim ve Refah Ayşenur OKATAN Sağlık, Demografik Değişim ve Refah Ulusal İrtibat Noktası 23 Kasım 2015
Avrupa Birliği Çerçeve Programlarında Sağlık Sağlık, Demografik Değişim ve Refah Alanı, AB Ufuk 2020 Programı, Toplumsal Sorunlara Çözümler bileşeni altında yer alan ve 7,4 milyar Euro luk bütçesiyle en büyük bütçeye sahip alt alandır. 6. ÇP 2002-2006 (5 yıl) 2,2 Milyar Euro 7. ÇP 2007-2013 (7 yıl) 6,1 Milyar Euro U2020 2014-2020 (7 yıl) 7,4 milyar Euro
3. Bileşen: Toplumsal Sorunlara Çözümler Programın Toplam Bütçesi (milyar ) 29,7 Sağlık, demografik değişim ve refah 7,47 Gıda Güvenliği, sürdürülebilir tarım, deniz ve denizcilik araştırmaları ve biyo-ekonomi Güvenli, temiz ve verimli enerji 6 Akıllı, yeşil ve entegre ulaştırma 6,3 İklim değişikliği, çevre, kaynak verimliliği ve ham maddeler 3 3,9 Değişen Dünya da Avrupa - Kapsayıcı, yenilikçi ve yansıtıcı toplumlar 1,3 Güvenli Toplumlar - Avrupa ve Vatandaşlarının Güvenliğinin ve Bağımsızlığının Korunması 1,7
Sağlık, Demografik değişim ve Refah Amaç/Kapsam Sağlığın, sağlıklı yaşlanmanın ve hastalıkların sebep ve mekanizmalarının anlaşılması Sağlığın takibi ve hastalık önleme, teşhis, tedavi ve gözlem sistemlerinin kurulması Yaşlanan nufüsun aktif ve sağlıklı kalması için destek mekanizmalarının geliştirilmesi Sağlık hizmetleri için yeni modellerin ve araçların geliştirilmesi ve test edilmesi Avrupa vatandaşlarının refahının korunması Değişen demografik dengeye uygun sağlık sistemlerinin oluşturulması Pazara yönelik çıktıların oluşturulması yönünde çalışmalar
Çağrı Bilgileri Alt konu başlıkları kapsamında yapılacak araştırma projeleri, seçilen bir odak konu etrafında şekillendirilmektedir. 2016-2017 Çalışma Programı ile belirlenen : 2016-2017 Odak alan çağrısı : Personalized Medicine Sağlığın kişiselleştirilmesi (PM) H2020-PM-2016 2016 ve 2017 yılları toplam çağrı bütçesi: 700 milyar Euro 2016 çağrı açılış tarihi: 20 Ekim 2015 2016 çağrı kapanış tarihleri: Single stage: 16 Şubat 2016 / 13 Nisan 2016
2016-2017 Çağrılarında Desteklenmesi Planlanan Konular
2016-2017 Çağrı Kapsamı 2016-2017 yılı Odak Çağrısı : Personalising Medicine Sağlığın Kişiselleştirilmesi 1) Personalised medicine 2) Chronic and rare diseases 3) Infectious diseases 4) Mental health 5) E/M-health 6) Active & Healthy ageing 7) Data security & Big Data 8) Robotics 9) Patient empowerment
1.1 Understanding health, well-being and disease PM 1 2016: Multi omics for personalised therapies addressing diseases of the immune system Integrating omics data (genome,epigenome,proteome,metabolome and microbiome data) with innovative imaging,functional,structural and lifestyle/environmental data and combining these with disease-oriented functional analyses to understand health and disease Proposals must build on data from IHEC (International Human Epigenome consortium) or other international initiatives Expected Impact: Translate big data and basic research results in to clinical applications Exploiting data from IHEC and data from other international initiatives Identify and select new biomarkers for clinical validation Develop new targeted therapies for diseases of the immune system Proje Tipi: Research and Innovation Action Bütçe: 12-15 Milyon Avro Kapanış Tarihi: 13/04/2016
1.1 Understanding health, well-being and disease PM 4 2016: Networking and optimising the use of population and patient cohorts at EU level Maximizing the exploitation of cohorts by bringing together national and/or European cohorts with common scientific interests (across diseases,birth,gender,mothers,elderly) and by using new technologies (ICT, social platforms) and new type of data (genetic,geographical,ehealth records) Proposals should provide expanded resources and knowledge on health and disease determinants, onset and course of diseases, clinical, public health and socio-economic research. Expected Impact: Making conceptual, methodological and analytical contributions Novel info on health maintenance, onset and course of diseases to tailor diagnosis and to optimise prevention and treatment Optimise the use of populations cohorts in defining/improving clinical practices and public health policy Proje Tipi: Research and Innovation Action Bütçe: 8-10 Milyon Avro Kapanış Tarihi: 13/04/2016
1.2 Preventing disease PM 6 2016: Vaccine development for malaria and/or neglected infectious diseases Addressing bottlenecks in the discovery, preclinical and early clinical development of new vaccine candidates(antigens/adjuvants) for malaria and/or neglected infectious diseases A) The larger platforms (developing multiple vaccine candidates and/or vaccines for multiple diseases) Take advantage of recent advances in vaccinology (in silico analysis and novel in vitro/vivo immunoscreens) or Establish completely new approaches for the discovery and selection of novel immunogenic antigens and/or novel formulations/combinations for the generation of new vaccine candidates Proje Tipi: Research and Innovation Action Bütçe: 15-20 Milyon Avro Kapanış Tarihi: 13/04/2016
1.2 Preventing disease PM 6 2016: Vaccine development for malaria and/or neglected infectious diseases Addressing bottlenecks in the discovery, preclinical and early clinical development of new vaccine candidates(antigens/adjuvants) for malaria and/or neglected infectious diseases B) Smaller proposals (focusing on a single disease and/or a single vaccine candidate) Innovative and comprehensive approaches to tackle one or more of the major bottlenecks in vaccine development for the specific disease Expected Impact: Delivering new vaccine candidates or move existing ones along the vaccine candidate pipeline Reduction in the cost associated with late stage vaccine failure Increase the number and quality of vaccine candidates for malaria and neglected infectious diseases Proje Tipi: Research and Innovation Action Bütçe: 3-5 Milyon Avro Kapanış Tarihi: 13/04/2016
1.3 Treating and managing diseases PM 9 2016: New therapies for chronic diseases Focusing on clinical trial(s), supporting proof of concept of clinical safety and efficacy in humans of novel therapies (pharmacological/non-pharmacological) or the optimisation of available therapies (repurposing) for chronic non-communicable or chronic infectious diseases Preclinical research should be completed Sound feasibility assessment (justified by available publications or provided preliminary results Phase 3 and Phase 4 clinical trials are excluded Expected Impact: New or optimised therapeutic strategies to generate advances in clinical practice and care for chronic non-communicable or chronic ingectious diseases Improve therapeutic outcome of major chronic health issues with significant impact on disease burden of individual patients and health care systems Proje Tipi: Research and Innovation Action Bütçe: 4-6 Milyon Avro Kapanış Tarihi: 13/04/2016
1.3 Treating and managing diseases PM 11 2016: Clinical research on regenerative medicine Focusing on clinical trial(s), supporting proof of concept of clinical safety and efficacy in humans of novel therapies (pharmacological/non-pharmacological) or the optimisation of available therapies (repurposing) for chronic non-communicable or chronic infectious diseases Target regenerative medicine therapies ready for clinical (in-patient) research Focus on one specific clinical phase of work Present appropriate preclinical and toxicology data for Phase I proposal and preliminary results for later phase proposals Justification for chosen disease or condition Expected Impact: New approaches to currently untreatable diseases Results by means of in-patient regenerative medicine research Stimulation of growth and competitiveness of EU regenerative medicine Shift investments in fundamental research into regenerative medicine Proje Tipi: Research and Innovation Action Bütçe: 4-6 Milyon Avro Kapanış Tarihi: 13/04/2016
1.4 Active ageing and self-management of health PM 14 2016: EU-Japan cooperation on Novel ICT Robotics based solutions for active and health ageing at home or in care facilities Joint research and innovation proposals for developing and demonstrating advanced ICT Robotics based solutions for extending active and healthy ageing in daily life System integration approaches between robotics devices, intelligent living environments( robots, home sensor networks Novel service models for facilitating prolonged independent living (services as maintenance of cognitive function, improvements in social situation as reduction of isolation/loneliness) Designed solutions towards different histories and cultures Realistic test sites in both EU and Japan Expected Impact: Improvement of efficiency in care providers Reducing caregivers burden due to work sharing with robots Improving quality of life of older persons and their carers Providing high quality service corresponding to the needs in daily lives of older persons Proje Tipi: Research and Innovation Action Bütçe: 1-2 Milyon Avro Kapanış Tarihi: 12/04/2016
1.5 Methods and Data PM 18 2016: Big data supporting Public Health policies Focusing on how to better acquire, manage, share, model, process and exploit the huge amount of data to develop integrated solutions supporting public health authorities of MS and AC in healthcare system management, long term policy making and actionable insights at the point of care providing. Systems (relevant solutions) for; Determining and monitoring the combined effects of environment, lifestyle and genetics on public health Enabling early identification of effects having large impact on health Focusing on governance of Big Data to use it proficiently across organisations and at policy levels Focusing on inclusion of suitable approaches towards securing security and privacy issues Expected Impact: Mapping comprehensive big data in a reachable and manageable way Develop innovative approaches to improve risk stratification methodologies Turning large amounts of data into actionable information to authorities for public health activities Proje Tipi: Research and Innovation Action Bütçe: 3-5 Milyon Avro Kapanış Tarihi: 16/02/2016
1.6 Health care provision and integrated care PM 21 2016: Implementation research for scaling-up of evidence based innovations and good practices in Europe and low- and middle-income countries Improving the functioning and sustainability of health systems by implementation research on scaling up evidence based innovations and good practices intervention Replicating and scaling up an innovative and well-researched comprehensive intervention in the field of health systems Scaling up within Europe and in low- and middle-income countries (LMIC) Selecting interventions more responsive, person-centred, safe, effective and efficient in health services/systems Its impact should be broad, addressing economic and social benefits Relevant stakeholders and end-users of research should be identified and involved throughout project lifetime Expected Impact: A larger group of citizens benefit from the studied health system intervention Facilitating the transferability of these practices More effective, efficient and equitable health systems/services Proje Tipi: Research and Innovation Action Bütçe: 4-6 Milyon Avro Kapanış Tarihi: 13/04/2016
2017 yılında açılacak çağrılar SC1-PM-02-2017 : New concepts in patient stratification SC1-PM-03-2017 : Diagnostic characterisation of rare diseases SC1-PM-07-2017 : Promoting mental health and well-being in the young SC1-PM-08-2017 : New therapies for rare diseases SC1-PM-10-2017 : Comparing the effectiveness of existing healthcare interventions in the adult population SC1-PM-11-2017 : Clinical research on regenerative medicine SC1-PM-15-2017 : Personalised coaching for well-being and care of people as they age SC1-PM-16-2017 : In-silico trials for developing and assessing biomedical products SC1-PM-17-2017 : Personalised computer models and in-silico systems for well-being SC1-PM-20-2017 : Development of new methods and measures for improved economics evaluation and efficiency measures in the health sector
Teşekkürler
A.Özge GÖZAY & Ayşenur OKATAN Sağlık, Demografik Değişim ve Refah Alanı Ulusal İrtibat Noktası AB Çerçeve Programlar Ulusal Koordinasyon Ofisi ULAKBİM YÖK Binası B5 Blok Bilkent Telefon: + 90 (312) 298 9425/04 E-posta: ncphealth@tubitak.gov.tr aysenur.okatan@tubitak.gov.tr